UPDATE 1-Bayer, Versant invest $225 million in biotech venture

TORONTO, Dec 12 (Reuters) - German chemicals and healthcare

group Bayer said it had set up a joint venture with

U.S. life sciences venture capital firm Versant Ventures to

invest $225 million in stem...

Read more